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Intestinal epithelial cells are exposed to both innoc-
uous and pathogenic microbes, which need to be
distinguished to mount an effective immune
response. To understand the mechanisms under-
lying pathogen recognition, we investigated how
Pseudomonas aeruginosa triggers intestinal innate
immunity in Caenorhabditis elegans, a process inde-
pendent of Toll-like pattern recognition receptors.
We show that theP. aeruginosa translational inhibitor
Exotoxin A (ToxA), which ribosylates elongation
factor 2 (EF2), upregulates a significant subset of
genes normally induced by P. aeruginosa. Moreover,
immune pathways involving the ATF-7 and ZIP-2
transcription factors, which protect C. elegans from
P. aeruginosa, are required for preventing ToxA-
mediated lethality. ToxA-responsive genes are not
induced by enzymatically inactive ToxA protein but
can be upregulated independently of ToxAby disrup-
tion of host protein translation. Thus, C. elegans has
a surveillancemechanism to recognize ToxA through
its effect on protein translation rather than by direct
recognition of either ToxA or ribosylated EF2.
INTRODUCTION
Intestinal epithelial cells (IECs) are continuously exposed to a
complex environment populated with a vast diversity of both
innocuous and pathogenic microbes. To mount an appropriate
immune response, it is essential for these cells to distinguish
between pathogens and commensals. It remains unclear,
however, how IECs can recognize and react to virulent microbes
while ignoring their innocuous counterparts.
In the current paradigm of innate immunity, pathogens are
primarily detected by host pattern recognition receptors
(PRRs) that recognize specific microbial features called
microbe- or pathogen-associated molecular patterns (MAMPs/
PAMPs) (Medzhitov, 2009). However, this model fails to address
how MAMPs/PAMPs such as peptidoglycan can be used to
distinguish between pathogenic and nonpathogenic bacteria.
Alternate theories propose that metazoan immune responses364 Cell Host & Microbe 11, 364–374, April 19, 2012 ª2012 Elseviercan also be activated by indirect evidence of infection. Indeed,
such a phenomenon has been observed in plants, which can
recognize pathogens by the disruption of cellular homeostasis
caused by pathogen-encoded virulence factors (effector-trig-
gered immunity) (Jones andDangl, 2006). Similarly, inDrosophila
melanogaster, microbial virulence factors have recently been
shown to initiate an immune response bymodifying host proteins
(Boyer et al., 2011). In mammals, the release of molecules such
as DNA, uric acid, and ATP from damaged tissues can activate
immunemechanisms (Kono andRock, 2008). Moreover, concur-
rent inhibition of protein synthesis by secreted Legionella
pneumophila effector proteins and exposure to a MAMP/
PAMP upregulate immune genes in macrophages (Fontana
et al., 2011). These indicators of pathogen activity have been
referred to as patterns-of-pathogenesis or damage-associated
molecular patterns (DAMPs) (Vance et al., 2009). In general,
however, the metazoan surveillance and signaling pathways
involved in these postulated mechanisms of pathogen detection
remain to be discovered.
We are using the nematode Caenorhabditis elegans to investi-
gate the mechanisms by which IECs identify pathogens. As
C. elegans lack professional immune cells, IECs serve as the
primary defense against ingested pathogens such as the human
opportunistic pathogen Pseudomonas aeruginosa (Irazoqui
et al., 2010b; Pukkila-Worley and Ausubel, 2012). The
P. aeruginosa strain PA14 accumulates in the C. elegans intes-
tinal lumen, causes host damage and upregulation of antimicro-
bial genes, and kills the nematode host (Irazoqui et al., 2010b;
Pukkila-Worley and Ausubel, 2012). C. elegans defense against
PA14 involves several parallel signaling pathways defined by
PMK-1 p38 MAPK, a bZIP transcription factor called ZIP-2,
and the G protein-coupled receptor FSHR-1 (Irazoqui et al.,
2010b; Pukkila-Worley and Ausubel, 2012), Interestingly,
C. elegans does not encode any recognizable homologs of the
NF-kB transcription factor, and its single Toll-like receptor
(TLR), TOL-1, does not seem to play a key role in immunity
(Irazoqui et al., 2010b; Pujol et al., 2001; Pukkila-Worley and
Ausubel, 2012). InC. elegans, theP. aeruginosa-encoded signals
that activate immune pathways and the corresponding PRRs, if
any, are unknown.
Recent experiments show that heat-killed P. aeruginosa or
virulence-attenuated mutants induce much lower levels of host
gene expression than wild-type pathogen (Pukkila-Worley and
Ausubel, 2012), suggesting that C. elegans immunity is triggered
by DAMPs generated during a P. aeruginosa infection and/or byInc.
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Figure 1. The Immune Reporter irg-1::GFP Is Activated by ToxA and
Translational Inhibitors but Not by Inactive ToxA Protein
A C. elegans strain containing the irg-1::GFP reporter was exposed to
P. aeruginosa PA14 (A), E. coli expressing either an empty expression vector
(B) or ToxA (C), the translational elongation inhibitors hygromycin (D) or G418
(E), or ToxA in conditions in which it causes less cellular damage because it is
missing an essential catalytic residue (ToxAE575D; F) or because C. elegans
lacks its diphthamide target (dph-1mutant; G). All animals were exposed to the
indicated condition for 24 hr starting at the L4 stage. Red pharyngeal
expression is due to the coinjection marker myo-2::mCherry and confirms the
presence of the transgene. All images were taken at the same time using the
same camera settings. Scale bar, 100 mm. See also Figure S1.
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plants. Based on these data, we hypothesized that DAMP
signals or host modifications generated by a singleP. aeruginosa
factor might be sufficient to trigger an immune response.
However, the P. aeruginosa mutants that exhibit the most aviru-
lent phenotypes in C. elegans correspond to global transcrip-
tional regulators that control the activity of many downstream
effector genes (Tan et al., 1999b). We therefore reasoned that
it would be difficult to identify the hypothesized eliciting factor(s)
by testing P. aeruginosa virulence-related mutants. Instead, weCell Hengineered a normally nonpathogenic E. coli strain to produce
the P. aeruginosa-encoded AB toxin Exotoxin A (ToxA), which
catalyzes the ADP ribosylation of elongation factor 2 (EF2) by
targeting the EF2 diphthamide moiety, a posttranslationally
modified histidine, thereby blocking protein synthesis (Yates
et al., 2006).
ToxA is expressed in more than 90% of clinical P. aeruginosa
isolates, high toxA transcription levels are associated with
severe infections (Bjorn et al., 1977; Matar et al., 2002), and
toxA-deficient strains are attenuated in animal virulence assays
(Fogle et al., 2002; Miyazaki et al., 1995; Nicas and Iglewski,
1985; Rahme et al., 1995). Additionally, as shown in the accom-
panying paper, ToxA inhibits protein synthesis inC. elegans IECs
during a PA14 infection (Dunbar et al., 2012). Importantly, toxins
encoded by other pathogens also ribosylate EF2, including
diphtheria toxin, the major virulence factor of Corynebacterium
diphtheriae, and cholix toxin from Vibrio cholerae (Jorgensen
et al., 2008; Yates et al., 2006). We therefore theorized that
C. elegansmay be able to senseP. aeruginosa andmultiple other
pathogens by monitoring their common molecular target (the
diphthamide residue), EF2 function, or protein translation in
general.
In this paper, we present evidence that C. elegans has surveil-
lance machinery that recognizes ToxA indirectly by detecting
ToxA-mediated translational inhibition. This recognition acti-
vates a potent transcriptional response in the worm that is
partially dependent on known immune pathways. Moreover,
the ZIP-2, PMK-1 MAPK, and FSHR-1 signaling pathways,
which are necessary for resistance against P. aeruginosa,
protect C. elegans from ToxA-mediated killing. In an accompa-
nying paper in this issue of Cell Host & Microbe, Dunbar et al.
(2012) show that P. aeruginosa inhibits protein synthesis in
C. elegans intestinal cells, which triggers increased levels of
ZIP-2 protein and its downstream factors. Together, these
studies demonstrate that the activity of a P. aeruginosa virulence
factor activates a subset of C. elegans immune genes indepen-
dently of either direct recognition of a bacterial-encoded mole-
cule or effector-mediated modification of a host protein.
RESULTS
ToxA Upregulates a Subset of the Genes Induced
by P. aeruginosa
To determine if C. elegans can detect and respond to an indi-
vidual P. aeruginosa factor, we used the pET100 plasmid vector
to express the P. aeruginosa PA14 toxA gene in a normally
nonpathogenic strain of E. coli (BL21 star). We fed these bacteria
to C. elegans containing transcriptional immune reporters
for irg-1 or F35E12.5, two genes robustly upregulated by
P. aeruginosa PA14 (Bolz et al., 2010; Estes et al., 2010; Troemel
et al., 2006). As expected, PA14 induced expression of irg-1::
GFP and F35E12.5::GFP, while E. coli expressing an empty
pET100 vector did not (Figures 1A and 1B and see Figure S1A
online). In contrast, E. coli expressing ToxA strongly activated
irg-1::GFP (Figure 1C). However, ToxA does not fully mimic
a P. aeruginosa infection, as ToxA failed to upregulate the
F35E12.5::GFP reporter (Figure S1A) or eight other representa-
tive P. aeruginosa-responsive genes (Figure S1B). ToxA was
also unable to induce the clec-60::GFP reporter (Figure S1A),ost & Microbe 11, 364–374, April 19, 2012 ª2012 Elsevier Inc. 365
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Figure 2. ToxA Induces a Subset of P. aeruginosa-Induced Genes
through Several Signaling Pathways
(A) Venn diagrams comparing the overlaps in genes activated by ToxA, Gram-
negative P. aeruginosa PA14 (Troemel et al., 2006), and either the yeast
C. albicans (Pukkila-Worley et al., 2011) or Gram-positive S. aureus (Irazoqui
et al., 2010a). All microarrays were conducted with the Affymetrix GeneChip
platform using animals infected at the L4/young adult stage and collected after
24 hr (ToxA), 8 hr (S. aureus), or 4 hr (PA14, C. albicans). See also Figure S2.
(B and C) qRT-PCR analysis in different mutant backgrounds of genes nor-
mally activated by ToxA. **, genes with R10-fold lower induction to ToxA as
compared to wild-type N2 animals with p < 0.05. *, genes withR5-fold lower
induction to ToxA as compared to N2 with p < 0.05. Results shown are an
average of six (N2) or three (pmk-1, zip-2, fshr-1) biological replicates. Error
bars represent SEM p values determined with a two-tailed unpaired t test.
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366 Cell Host & Microbe 11, 364–374, April 19, 2012 ª2012 Elsevierwhich is strongly activated by Staphylococcus aureus (Irazoqui
et al., 2008).
To determine whether ToxA activates other P. aeruginosa-
responsive genes in addition to irg-1, we performed genome-
wide transcriptional profiling analyses of wild-type animals
exposed to E. coli expressing either ToxA or an empty pET100
vector. Using Affymetrix GeneChips, we identified 174 genes
whose expression changed at least 2-fold when exposed to
ToxA (144 upregulated and 30 downregulated; see Table S1).
Based on previous Affymetrix profiling experiments, 68 of
these 144 upregulated genes are also induced during the first
4 hr of a P. aeruginosa infection (p < 1 3 1013; Figure 2A), and
10 of the remaining 76 ToxA-activated genes respond to
P. aeruginosa at a later time point (Troemel et al., 2006).
To further investigate the specificity of the ToxA response,
we used publically available transcriptional profiling data sets
to determine how many ToxA-activated genes are upregulated
by other C. elegans pathogens (Irazoqui et al., 2010a; Pukkila-
Worley et al., 2011). We found that ToxA only activates 3 of the
124 genes induced by infection with the fungal pathogen
Candida albicans and 7 of the 189 genes induced by infection
with S. aureus (neither overlap is significant, p > 0.1 for both
comparisons) (Figure 2A).
We next tested whether ToxA acts as a general intestinal
stressor by determining the number of ToxA-responsive genes
that are also triggered by the heavy metal cadmium or the
pore-forming toxin Cry5B (Huffman et al., 2004). Whereas
ToxA induces the expression of a significant number of these
stress-response genes (46 of 453 cadmium-responsive genes
and 39 of 385 Cry5B-responsive genes), the majority of these
‘‘overlapping’’ genes (74%and 79%, respectively) are also upre-
gulated by P. aeruginosa (Figure S2). Taken together, these data
show that ToxA activates a particular subset of the genes
induced when C. elegans is infected with P. aeruginosa PA14,
but does not trigger broad immune or stress responses.
Since ToxA upregulates a subset of P. aeruginosa-responsive
genes, we investigated whether the same immune pathways
are required for both ToxA- and P. aeruginosa-mediated gene
induction. Previous genome-wide profiling experiments identi-
fied genes whose induced or basal expression requires the
ZIP-2 or PMK-1 MAPK pathways, respectively (Estes et al.,
2010; Troemel et al., 2006). We found that ToxA upregulated
19 of the 25 genes specified by Estes et al. that are activated
downstream of ZIP-2 (p < 5 3 104) but only 5 of the 101 genes
identified by Troemel et al. that require the PMK-1 p38 MAPK
for basal expression (p > 0.05). This PMK-1microarray, however,
did not identify genes that require PMK-1 for infection-mediated
upregulation, and some of the genes whose induction requires
PMK-1 do not require PMK-1 for basal expression (Troemel
et al., 2006). To investigate the possibility that additional ToxA-
responsive genes are PMK-1 dependent and to extend our
analysis, we selected a representative panel of highly upregu-
lated, ToxA-responsive genes to assay by qRT-PCR in different
mutant backgrounds. We selected 11 genes, 8 of which (with the
exception of arrd-3, T19C9.8, and dur-1) have been reported to
be upregulated by P. aeruginosa, and verified that 10 of these
genes were induced as expected in wild-type animals exposed
to ToxA (Figures 2B and 2C; data not shown for dur-1). This
verification rate is consistent with prior microarray analyses ofInc.
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Figure 3. Multiple Pathways Contribute to ToxA Resistance
Life span of wild-type N2 (A), zip-2 mutant (B), p38 MAP kinase pathway mutant (C), fshr-1 mutant (D), daf-16 mutant (E), or skn-1 RNAi (F) worms fed E. coli
expressing either ToxA or an empty expression vector starting at the L4 stage. Circles represent animals fed ToxA, and triangles indicate vector control food.
See also Figure S3.
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et al., 2011). qRT-PCR analysis in different mutant strains
showed that irg-1 and two previously uncharacterized genes
(F11D11.3 and oac-32) required ZIP-2, two genes (oac-32 and
T24E12.5) were partially dependent on PMK-1, and two genes
(arrd-3 and T19C9.8) were at least partially dependent on
FSHR-1 for ToxA-mediated activation (Figure 2B). The four re-
maining genes (irg-2, K10D11.2, pgp-6, and K10G4.3) were
induced in all three mutants tested (Figure 2C). Interestingly,
ZIP-2 was required to activate irg-2 in response to
P. aeruginosa (Estes et al., 2010), but not in response to ToxA,
although we did observe that the basal expression of irg-2
was >30-fold lower in zip-2(tm4248) mutants compared to
wild-type worms.
We additionally determined whether two conserved pathways
that are involved in both general stress and immune responses
are similarly involved in ToxA-dependent gene activation.
Specifically, we tested the potential involvement of the Nrf1/2/3
ortholog SKN-1 (van der Hoeven et al., 2011) and the insulin
signaling pathway mediated by the FOXO transcription factor
DAF-16 (Garsin et al., 2003). Unlike the immune pathways above,
ToxA-induced expression of all 10 genes was unaffectedCell Hfollowing skn-1 RNAi or in daf-16(mgDf47) mutants (data not
shown). Moreover, exposure to ToxA was not sufficient to cause
nuclear translocation of a DAF-16::GFP translational fusion (data
not shown) (Henderson and Johnson, 2001).
Immune Pathways Are Required for ToxA Resistance
Since ToxA is a potent cytotoxin that activates C. elegans
immune genes, we were surprised to observe no difference in
the life span of wild-type worms fed E. coli expressing either
ToxA or the empty vector control (p = 0.8; Figure 3A), suggesting
that the wild-type immune response may counteract its toxic
effects. To test this possibility, we asked whether immunocom-
promised worms are similarly unaffected by ToxA. Since ZIP-2
acts upstream of many ToxA-responsive genes (Figure 2), we
exposed zip-2(tm4067) or zip-2(tm4248) mutant worms to
ToxA-expressing E. coli and discovered that, unlike wild-type
animals, zip-2 mutants had significantly shorter life spans when
fed ToxA as compared to the vector control (p < 5 3 109 for
both alleles; Figure 3B).
We next asked whether, as with the ZIP-2 pathway, other
immune pathways that defend C. elegans from P. aeruginosa
similarly prevent ToxA lethality. We found that the p38 MAPKost & Microbe 11, 364–374, April 19, 2012 ª2012 Elsevier Inc. 367
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Figure 4. Mutating ToxA or Removing the C. elegans Diphthamide
Modification Inhibits ToxA-Mediated Lethality
(A) Life span comparison of pmk-1(km25) mutants fed either wild-type ToxA,
the catalytic mutant ToxAE575D, or vector control food.
(B) Life span comparison between wild-type N2 and diphthamide synthesis
mutants when fed ToxA following pmk-1 RNAi. All assays were started with L4
stage animals.
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Blocking Translation Activates C. elegans Immunitymutant pmk-1(km25) was also sensitive to ToxA and died at a
faster rate than zip-2 mutants (p < 5 3 109; Figure 3C).
PMK-1 acts directly downstream of the MAPKKK NSY-1 and
MAPKK SEK-1 and upstream of the ATF-7 transcription factor
(Pukkila-Worley and Ausubel, 2012). Similarly to pmk-1mutants,
nsy-1, sek-1, and atf-7 mutants were susceptible to ToxA (p <
5 3 109 for all mutants; Figure 3C). We also determined that
loss of the FSHR-1 pathway resulted in ToxA sensitivity,
although the effect was less pronounced than for the zip-2 and
pmk-1 mutants (p < 1 3 106; Figure 3D). Finally, we tested
whether the stress response pathways mediated by DAF-16
and SKN-1 were required for ToxA resistance and found that
loss of either protein conferred a slight susceptibility to ToxA
(Figures 3E and 3F). Animals lacking both pmk-1 and zip-2,
pmk-1 and fshr-1, pmk-1 and daf-16, or pmk-1 and skn-1
did not show faster ToxA-dependent lethality than single
pmk-1(km25) mutants (data not shown), potentially indicating
that the genes regulated by pmk-1 are epistatic to those depen-
dent on other immune pathways. Alternatively, the critical ToxA-
defense genes may be regulated by multiple pathways, or this
E. coli ToxA killing assay is not sensitive enough to detect subtle
differences in ToxA susceptibility.
The inability of immunocompromised worms to resist ToxA as
effectively as wild-type worms suggests that ToxA may be
responsible for the increased lethality of these immune pathway
mutants during a P. aeruginosa infection. To test this hypothesis,
we compared the virulence of wild-type P. aeruginosa PA14 and
a toxA mutant toward either ToxA-resistant N2 animals or the
extremely ToxA-sensitive pmk-1(km25) mutant. Although ToxA
is important for the inhibition of C. elegans intestinal translation
during a P. aeruginosa infection (Dunbar et al., 2012), we found368 Cell Host & Microbe 11, 364–374, April 19, 2012 ª2012 Elsevierthat wild-type PA14 and the PA14 toxA mutant were indistin-
guishable in their ability to kill either N2 or pmk-1(km25)
animals (p > 0.1 for both C. elegans strains; Figure S3). While
our laboratory previously reported that the PA14 toxA mutant
exhibited a modest delay in killing wild-type N2 worms (Tan
et al., 1999a), we speculate that this apparent discrepancy
with our current results is due to minor methodological differ-
ences. Regardless, loss of ToxA does not severely hinder
P. aeruginosa from killing even a ToxA-sensitive C. elegans
strain, suggesting that P. aeruginosa encodes multiple, redun-
dant virulence determinants that together contribute to killing
the worms.
C. elegans Responds to Translational Inhibition
We considered three general mechanisms by which ToxA could
elicit an immune response. The ToxA protein could be directly
recognized as a MAMP/PAMP, EF2 ribosylation by ToxA could
be sensed directly, or ToxA could be indirectly detected by
surveying for the inhibition of protein synthesis, the consequence
of which might include the generation of DAMPs. To distinguish
among these possibilities, we first tested whether the irg-1::GFP
reporter could be activated by a ToxA protein that is defective in
EF2 ribosylation (MAMP/PAMP-like mechanism) or could be
activated by disrupting protein synthesis independently of
ToxA (DAMP/effector-like mechanism).
To mimic a ToxA-mediated translational block, we used the
aminoglycoside antibiotics hygromycin B (hereafter referred to
as ‘‘hygromycin’’) and G418, both of which bind to the eukaryotic
ribosome and prevent elongation of the polypeptide chain
(Eustice and Wilhelm, 1984). While prolonged exposure to these
drugs resulted in nematode lethality (Figure S4A), at early times
in the treatment both antibiotics triggered the upregulation of
irg-1::GFP (Figures 1D and 1E).
We next tested whether irg-1::GFP is upregulated by a catalyt-
ically inactive ToxA protein that does not inhibit host translation.
For this experiment, we constructed a ToxAE575D mutant,
which is missing a key catalytic residue directly involved in the
ADP-ribosylation of EF2 but not required for the stability or
cellular trafficking of ToxA (Killeen and Collier, 1992; Lukac
et al., 1988; Pastrana et al., 2008). We determined by western
blotting analysis that both wild-type ToxA and ToxAE575D
mutant proteins were expressed by E. coli at comparable levels
(see the Experimental Procedures). To confirm that the Tox-
AE575Dmutant is attenuated inC. elegans, we assayed its effect
on pmk-1(km25) mutants. As expected, E. coli expressing Tox-
AE575D did not rapidly kill these animals like E. coli expressing
wild-type ToxA. It is worth noting that the ToxAE575D mutant
may contain residual catalytic activity, as exposure to it slightly
shortened the nematode life span as compared to the vector
control (Figure 4A). In a complementary set of experiments, we
inhibited the function of ToxA by preventing the formation of its
diphthamide target. We confirmed that C. elegans mutants of
the diphthamide synthesis genes dph-1 and dph-3were insensi-
tive to wild-type toxin by feeding them E. coli expressing ToxA
after knocking down pmk-1 with RNAi (p > 0.1 for both mutants;
Figure 4B). To ensure that dph-1 and dph-3 do not have
background RNAi mutations making them resistant to pmk-1
knockdown, we confirmed that both strains responded like
wild-type animals to RNAi targeting lin-29 and nhr-23 (data notInc.
Cell Host & Microbe
Blocking Translation Activates C. elegans Immunityshown) (Zhang et al., 2011). Thus, by using these two methods,
we could expose animals to ToxA without affecting host transla-
tion. When E. coli expressing ToxAE575D was fed to wild-type
C. elegans or E. coli expressing wild-type ToxA was fed to the
C. elegans dph-1 mutant, the irg-1::GFP reporter was not
induced, demonstrating that the presence of ToxA protein alone
was not sufficient to trigger the full C. elegans response (Figures
1F and 1G). Additional data supporting this conclusion are pre-
sented below.
To determine whether detecting ToxA’s inhibition of protein
synthesis can induce the complete ToxA response described
in Figure 2A, we carried out transcriptional profiling of wild-
type animals exposed to hygromycin. We identified 1,297 genes
whose expression was altered at least 2-fold by the inhibitor (861
induced and 436 repressed; see Table S2). Strikingly, of the 144
genes activated by ToxA, 136 (94%) were also upregulated by
hygromycin in the absence of ToxA (6.3 genes expected by
chance; Figure S4B). For those genes activated by both ToxA
and hygromycin, hygromycin induced an average 8-fold stronger
response than ToxA under the conditions of these transcriptional
profiling analyses. The larger effect of hygromycin on both the
number of genes impacted and the magnitude of their response
suggests thatC. elegans translation wasmore effectively disrup-
ted by the hygromycin treatment. Alternatively, hygromycin
could have multiple cellular targets and thus trigger a broad
response involving many nonspecific immune and stress genes.
To help distinguish these possibilities, we determined which
functional classes were overrepresented among the hygromy-
cin-induced genes using DAVID enrichment analysis (Huang
et al., 2009). Similar to ToxA, hygromycin preferentially upregu-
lated genes related to transcriptional regulation and innate
immunity (Figure S4C). Hygromycin also activated genes associ-
ated with protein kinase cascades, Ras-GTPases, and proteins
containing F box domains, all of which have been previously
directly or indirectly implicated in C. elegans pathogen defense
(Kim et al., 2002; Lundquist, 2006; Thomas, 2006). We addition-
ally identified enriched gene classes by analyzing our results in
the context of genemountains, which are clusters of coregulated
genes as determined by meta-array analysis (Kim et al., 2001).
Intestinal and antibacterial genes were disproportionally upregu-
lated following exposure to either hygromycin or ToxA (mountain
8 enriched 3- and 3.5-fold compared to the genome, respec-
tively, p < 0.01). In contrast, hygromycin, but not ToxA, upregu-
lated neuronal genes (mountains 1 and 6 each 2-fold enriched,
p < 0.01), suggesting that hygromycin may affect a wider variety
of targets than ToxA.
We further analyzed the specificity of hygromycin by deter-
mining the percent of hygromycin-induced genes that are also
triggered by the abiotic stresses and pathogens described
above. While hygromycin activated 42% of P. aeruginosa-
responsive genes, it only upregulated 25% and 23% of
C. albicans- and S. aureus-responsive genes, respectively,
which was similar to the overlap between these pathogens
and P. aeruginosa (21% and 27%, respectively). Furthermore,
many of the genes induced by both hygromycin and
either C. albicans or S. aureus were also upregulated by
P. aeruginosa, suggesting that these genes are not specific for
the response to a single type of pathogen (Figure S4D). Finally,
while hygromycin induced a greater percentage of stress genesCell H(35% of cadmium- and 40% of Cry5B-induced genes) than
P. aeruginosa (22% of cadmium- and 23% of Cry5B-induced
genes), many of the genes upregulated by both hygromycin
and either cadmium or Cry5B were also upregulated by
P. aeruginosa (Figure S4E). Based on these analyses, we
conclude that hygromycin activates the same general gene
classes as ToxA and does not broadly activate immune response
genes or a large subset of stress response genes. Instead, like
ToxA, hygromycin primarily upregulates a subset of the genes
specifically activated in response to infection by P. aeruginosa
PA14. The extensive overlap between genes induced by ToxA
and hygromycin suggests that ToxA-responsive genes are trig-
gered by the enzymatic function (translational inhibition) of ToxA.
To confirm our transcriptional profiling results and further rule
out the alternative hypothesis that recognition of ToxA protein
per se functions as an immune trigger, we analyzed the ten
genes in Figure 2, which are activated by ToxA and are predicted
bymicroarray analysis to be upregulated by hygromycin. Specif-
ically, we carried out qRT-PCR analysis under conditions that
distinguish direct and indirect recognition mechanisms. Consis-
tent with the profiling data, exposure to hygromycin was
sufficient to induce the expression of all ten genes (Figure 5A).
Moreover, these gene activations largely required the same
immune pathways as the ToxA response (Figure 5B). In contrast,
none of these ten genes were upregulated by E. coli expressing
the catalytic mutant ToxAE575D (Figure 5A). We also investi-
gated whether catalytically inactive ToxAE575D could amplify
an established immune response by acting as a secondary
trigger, but we found that simultaneous exposure to hygromycin
and E. coli expressing ToxAE575D did not significantly enhance
the level of activation compared to treatment with hygromycin
alone (p > 0.2 for each gene; Figure 5A). In addition, none of
the ten genes were upregulated by E. coli expressing wild-type
ToxA in either of the diphthamide mutants (Figure 5C). In
contrast, the diphthamide mutants responded to hygromycin
by activating these ten genes, confirming that they were still
capable of recognizing and reacting to translational inhibition.
Finally, we tested whether G418, a different ribosomal inhibitor,
would also trigger expression of these ToxA-activated genes.
When exposed to G418, six of the ten genes were upregulated,
indicating that their response was not specific to hygromycin
(Figure 5D). Exposure to G418 did not result in C. elegans
lethality as quickly as for hygromycin (Figure S4A), suggesting
that activation of the four uninduced genes may require a higher,
hygromycin-like, level of protein inhibition.
While hygromycin upregulated 94% of the ToxA-responsive
genes, we did identify eight genes that were induced by ToxA
and not hygromycin, although these genes were not highly
upregulated by ToxA (all eight genes induced <4.5-fold, and
four genes induced %2.5-fold). To further characterize these
transcripts, we tested which conditions triggered the expression
of a representative gene, clec-67 (upregulated 4.2-fold). As pre-
dicted from the microarray analysis, clec-67 was induced by
ToxA-encoding E. coli but not by hygromycin or G418. Like the
other genes tested in Figures 5A–5C, clec-67 was not activated
by E. coli expressing ToxAE575D or activated in dph-1(ok329) or
dph-3(ku432) mutants exposed to E. coli expressing wild-type
ToxA (Figure 5E), indicating that clec-67 is also not upregulated
by the ToxA protein itself.ost & Microbe 11, 364–374, April 19, 2012 ª2012 Elsevier Inc. 369
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Figure 5. ToxA Genes Are Upregulated by Translational Inhibition
but Not by Catalytically Inactive ToxA Protein
(A–D) qRT-PCR analysis of ToxA-responsive genes exposed to the indicated
condition. N2 animals were tested unless otherwise noted. As shown in (B),
four genes (irg-1, F11D11.3, T24E12.5, and arrd-3) required the same
pathways to respond to both hygromycin and ToxA (compare to Figure 2B).
Hygromycin-induced expression of oac-32 was reduced in zip-2 and
pmk-1 mutants (7- and 2-fold, respectively), but this reduction was not
statistically significant (p > 0.05). Both hygromycin and ToxA-induced
expression of T19C9.8 required fshr-1, but only hygromycin-mediated acti-
vation additionally required zip-2 and pmk-1. None of these gene inductions
depended on skn-1, but daf-16was necessary for the upregulation of T19C9.8
in response to hygromycin (11-fold reduction in daf-16[mgDf47] mutants,
p < 0.05). However, as with ToxA, exposure to hygromycin was not sufficient
to cause strong nuclear translation of DAF-16 (data not shown). **, genes
with R10-fold lower induction to hygromycin as compared to wild-type N2
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In this study, we established that the P. aeruginosa factor ToxA is
sufficient to trigger a C. elegans immune response and that
signaling pathways activated by P. aeruginosa infection and
mediated by PMK-1 p38 MAPK, ZIP-2, FSHR-1, DAF-16, and
SKN-1 also protect the nematode from ToxA-mediated killing
to varying extents. Through microarray analysis, we defined a
set of C. elegans genes that respond to an inhibition of transla-
tional elongation and determined that a significant number of
these genes are also activated by a P. aeruginosa infection.
Although C. elegans recognizes and reacts to ToxA, this recog-
nition does not appear to involve detection of the ToxA protein
per se. Catalytically inactive ToxA did not trigger the expression
of a representative set of genes upregulated by both ToxA and
hygromycin, and coadministering inactive ToxAwith hygromycin
did not elicit a stronger response than hygromycin alone. Simi-
larly, C. elegans diphthamide mutants, which are insensitive to
ToxA-mediated inhibition, did not activate the representative
ToxA-responsive genes when exposed to ToxA but did upregu-
late them following hygromycin treatment. We therefore con-
clude that the transcriptional response to ToxA is a consequence
of the enzymatic activity of ToxA resulting from its ribosylation
of EF2.
There are at least two mechanisms by which EF2 ribosylation
could activate an immune response. First, C. elegans could
have a receptor that recognizes the ribosylated diphthamide
residue. This mechanism is conceptually similar to the so-called
‘‘guard hypothesis’’ in plant immunity which postulates that plant
NB-LRR receptor proteins ‘‘guard’’ the targets of microbial
effector proteins (Jones and Dangl, 2006). Alternatively, ToxA-
mediated inhibition of protein synthesis could generate a
secondary signal, analogous to the DAMP hypothesis, which in
turn activates immune signaling. Our data show that 94% of
ToxA-responsive genes are induced by hygromycin, which, like
ToxA, blocks elongation of growing protein chains. This finding,
combined with the observation that disrupting protein synthesis
through genetic or chemical approaches activates the ZIP-2
signaling pathway (Dunbar et al., 2012), strongly suggests that
theC. elegans immune response is triggered by inhibiting protein
synthesis rather than by recognizing ribosylated EF2. However,
we have not eliminated the possibility that C. elegansmay simul-
taneously detect and react to ToxA-mediated ribosylation. Simi-
larly, we cannot rule out the possibility that theE. coli food source
used in these experiments contains MAMPs/PAMPs that func-
tion in conjunction with ToxA to activate immunity. However, it
is likely that C. elegans in their natural environment regularly
encounter innocuous Gram-negative bacteria like E. coli, and
so it is unclear how relevant putative MAMPs/PAMPs could be
for discriminating between pathogenic and benign microbes.
While we identified several pathways that are activated by
ToxA/translational inhibition, we do not know which specificanimals with p < 0.05. *, genes withR5-fold lower induction to hygromycin as
compared to N2 with p < 0.05. Results shown are an average of six (A and B,
N2 hygromycin; D, ToxA) or three (all remaining conditions) biological repli-
cates. Error bars represent SEM p values determined with a two-tailed
unpaired t test. See also Figure S4.
Inc.
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tion of immune genes. A recent report by Fontana et al. showed
that inhibiting translation in macrophages with L. pneumophila
virulence factors or pharmacological agents activates mamma-
lian immunity through an NF-kB-dependent mechanism (Fon-
tana et al., 2011). In these macrophages, blocking translation
prevents the synthesis of the NF-kB inhibitor IkB, thereby
enabling continuous NF-kB function. Although, as stated above,
we cannot rule out the possibility that C. elegans also receives
a MAMP/PAMP-like signal since they are in constant contact
with a bacterial food source, it is likely that the nematode
responds to translational disruption via a different mechanism,
since, unlike C. elegans, the macrophage response required
two simultaneous inputs: a translational inhibitor and a TLR
agonist (Fontana et al., 2011). The absence of an identifiable
ortholog for NF-kB in C. elegans further strengthens this
conclusion.
The data shown in Figure 5B demonstrated that the p38
PMK-1, ZIP-2, and FSHR-1 immune signaling pathways are
involved in the C. elegans response to translational inhibition. In
addition to our work, Li et al. have shown that PMK-1 phosphor-
ylation in C. elegans increases following exposure to a transla-
tional inhibitor or RNAi of endogenous translation factors
(Li et al., 2011), suggesting a mechanistic link between the iden-
tification of protein synthesis abnormalities and activation of
the p38 MAPK pathway. In addition to p38 MAPK signaling,
Dunbar et al. have shown that blocking translation upregulates
a ZIP-2::GFP reporter through a process that shares similarities
with amino acid starvation, which is regulated by inhibitory
upstreamORFs (uORFs) (Dunbar et al., 2012). It is an open ques-
tion whether mammalian cells have a mechanism for sensing
protein synthesis inhibition similar to the one that we and Dunbar
et al. have identified in C. elegans, although evidence has been
mounting in recent years suggesting that mammalian innate
immunity utilizes a variety of non-TLR receptors and signaling
pathways that may respond to DAMP-like signals (Medzhitov,
2009).
Our observations that wild-type immunocompetentC. elegans
can survive the lethal effects of ToxA and that P. aeruginosa
virulence is undiminished in a toxA mutant despite apparently
normal levels of intestinal translation, raise the question of
whether ToxA should be considered a virulence factor, at least
in the context of these laboratory C. elegans infection assays.
In the wild, it is likely that C. elegans is subjected to many
biotic and abiotic stresses and that C. elegans individuals may
often be functionally immunocompromised and potentially
susceptible to ToxA. On the other hand, if the main effect
of ToxA is to rapidly upregulate immune genes and not to
enhance virulence, ToxA could function analogously to a Type
III effector in a plant pathogen that elicits ETI in particular hosts
(Jones and Dangl, 2006). However, the analogy is imperfect,
since plant pathogens that elicit ETI are less virulent, whereas
in these experiments, PA14 strains expressing ToxA have the
same virulence toward C. elegans as a P. aeruginosa toxA
mutant.
The efficacy of the ToxA response suggests that C. elegans in
the wild may encounter virulent strains of P. aeruginosa or other
pathogens, such as C. diphtheriae, with toxins that have similar
enzymatic activities. Furthermore, protein synthesis can be dis-Cell Hrupted by many microbially synthesized xenobiotic compounds
such as antibiotics produced by actinomycetes in the soil. Thus,
the C. elegans immune response to protein synthesis inhibitors
may enable the nematode to quickly respond to diverse environ-
mental threats. In addition to mediating immune defenses, the
surveillance pathway(s) that recognizes translational inhibition
may function more generally to protect the worms against a
variety of biological and chemical onslaughts. Interestingly,
RNAi knockdown of translational components can enable
many beneficial phenotypes, including an extended life span
(Curran and Ruvkun, 2007; Hansen et al., 2007; Rogers et al.,
2011; Wang et al., 2010), increased stress resistance (Li et al.,
2011), and avoidance behaviors (Melo and Ruvkun, 2012).
Exposure of C. elegans to E. coli-expressing ToxA does not
increase N2 longevity, suggesting that the enhanced longevity
observed following the RNAi experiments described above
may be triggered by different levels of translational inhibition or
by alternative DAMP-like signals that are not generated by
ToxA. Alternatively, the negative effects of ToxA may outweigh
its potential benefits, including increased longevity.
Our data suggest that C. elegans at least partially recognizes
P. aeruginosa through the disruption of a core cellular
process, but it is unknown if this is the primary mechanism of
C. elegans pathogen identification, or whether it is unique for
P. aeruginosa and xenobiotics that inhibit translation. In addition
to the translational component knockdowns described above,
RNAi against many essential C. elegans genes, including those
involved in molting, proteasome machinery, and mitochondrial
processes, can both activate immune reporters and stimulate
a bacterial aversion behavior that resembles pathogen avoid-
ance (Melo and Ruvkun, 2012). Regardless of the results re-
ported here and those of Melo and Ruvkun, other data from
our laboratory indicate that C. elegans may recognize some
infectious microbes through more traditional MAMP/PAMP
mechanisms. For example, C. elegansmounts an immune reac-
tion to heat-killed avirulent S. aureus and C. albicans (Pukkila-
Worley and Ausubel, 2012).
In general, the relative roles of identifying highly conserved
MAMPs/PAMPs, microbial effectors, effector-modified host
proteins, or host damage caused by bacterial toxins and cellular
invasion remain to be determined for C. elegans as well as other
metazoans.MAMP/PAMP-triggered signalingmediated by TLRs
is well-established in insects and vertebrates. In addition, the
NAIP family of intracellular receptors has been recently shown
in mammals to directly recognize conserved components of
bacterial type III secretion systems, which are involved in the
delivery of a variety of virulence-related factors directly into the
host cell cytoplasm (Kofoed and Vance, 2011; Zhao et al.,
2011). Moreover, as described above, Boyer et al. show that
an immune response can be triggered in both insects and
mammalian cells by deamidation of a host RhoGTPasemediated
by the E. coli-encoded toxin CNF1, in a process that is indepen-
dent of MAMP/PAMP recognition (Boyer et al., 2011), and Fon-
tana et al. have shown that translational inhibitors can activate
mammalian immune genes, but only where there is concurrent
activation via a PRR pathway (Fontana et al., 2011). Our data,
however, suggest that the C. elegans ToxA response differs
from all of these examples because it does not appear to involve
the direct recognition of a bacterial-encoded molecule orost & Microbe 11, 364–374, April 19, 2012 ª2012 Elsevier Inc. 371
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ToxA-mediated activation of immunity in C. elegans only
requires the disruption of an essential cellular function. Whether
this involves specific DAMP signaling molecules and host recep-
tors remains to be elucidated.
EXPERIMENTAL PROCEDURES
Strains
C. elegans were maintained using standard methods (Brenner, 1974).
The following C. elegans strains were used in this study: N2 (wild-type),
pmk-1(km25), nsy-1(ag3), nsy-1(ok593), sek-1(km4), agIs219 atf-7(qd22
qd130), agIs219 atf-7(qd137), zip-2(tm4067), zip-2(tm4248), fshr-1(ok778),
daf-16(mgDf47), dph-1(ok329), dph-3(ku432), agIs17(irg-1::GFP), agEx39
(myo-2::mCherry, clec-60::GFP), acIs101[pDB09.1(F35E12.5::GFP); pRF4
[rol-6(su1006)]], ldl5007[skn-1B/C::GFP+pRF4[rol-6(su1006)]], and zls356IV
[daf-16::DAF-16::GFP+pRF4[rol-6(su1006)]]. ToxA proteins and the vector
control were expressed in E. coli BL21 Star (DE3) (Invitrogen). All RNAi clones
were obtained from the Ahringer library (Kamath and Ahringer, 2003) and
confirmed by sequencing. UCBPP-PA14 toxA was obtained from the Rahme
lab (Rahme et al., 1995).
Cloning
ToxA was amplified from PA14 genomic DNA with the primers 50-CACCATG
CACCTGATACCCCATTG and 50-CTACTTCAGGTCCTCGCGCG and inserted
into the pET100d vector using directional TOPO cloning (Invitrogen). E575 was
removed by site-directed mutagenesis with the primers 50-GGCGGGC
GCCTGACCATTCTCGGC and 50-GCCGAGAATGGTCAGGCGCCCGCC. To
test whether removing E575 affected ToxA expression or stability, both
ToxA and ToxAE575D were fused to green fluorescent protein (GFP). After
confirming that the GFP tag does not disrupt protein function (i.e., ToxA::GFP
is still lethal to pmk-1[km25] mutants), we determined that BL21 cells express
full-length ToxAE575D::GFP at the same concentration that they express
ToxA::GFP through western blot analysis with an anti-GFP antibody (ab290,
Abcam) and an anti-GAPDH antibody loading control (Pierce Antibodies).
C. elegans Life Span/Killing Assays
Synchronized animals were prepared by hypochlorite treatment and L1 arrest.
Synchronized L1 larvae were plated onto 6 cm NGM plates seeded with E. coli
OP50 or 6 cm RNAi plates prepared as described (Kamath and Ahringer,
2003). Animals were grown to the L4 stage at 20C and transferred to 6-well
assay plates prepared as described below. All assays were conducted at
25C and in the presence of FUDR (100 mg/ml) to inhibit progeny production.
Approximately thirty worms were transferred to each well, and at least three
replicates were performed for each condition. Animals were considered
dead when they failed to respond to the touch of a platinum wire (worm
pick). Animals that died by crawling up the side of the plate were censored
from the analysis. Each assay was performed a minimum of three times, and
a representative experiment was included in the paper. Survival curves were
compared using a log-rank test.
Assay Plate Preparation
Luria broth (LB) containing 100 mg/ml ampicillin was inoculated with an over-
night culture of E. coli (1:20 dilution), grown for 2 hr at 37C, induced with
IPTG to a final concentration of 1 mM, and grown an additional hour. Concen-
trated bacteria (103) was seeded onto NGM plates containing 5 mM IPTG and
100 mg/ml ampicillin and used immediately. For hygromycin and G418 exper-
iments, plates were dried for 1 hr before a mixture of inhibitor plus water was
spread evenly over the agar. Once this mixture soaked into the agar, the plates
were seeded with bacteria prepared as described above. Hygromycin B
(3.13 ml) (50.37 mg/ml in water, Sigma) or 12.5 ml of G418 (50 mg/ml in water,
Sigma) was added per milliliter of agar. P. aeruginosa slow killing plates were
prepared as described (Troemel et al., 2006).
RNA Extraction and Microarray Analysis
Worms were treated as described for the killing assays, with the exception that
4,000–6,000 L4 worms were plated onto 10 cm assay plates. After growing372 Cell Host & Microbe 11, 364–374, April 19, 2012 ª2012 Elsevieron the assay plates for 24 hr, worms were washed into a 15 ml conical tube
with water and rinsed once. The animals were resuspended in TRI Reagent
(Molecular Research Center) and frozen at80C. Once thawed, RNAwas ex-
tracted according to manufacturer’s protocols and purified with an RNeasy
column (QIAGEN). RNA samples were prepared and hybridized to Affymetrix
full-genome GeneChips for C. elegans at the Partners Center for Personalized
Genetic Medicine, Boston, MA, according to manufacturer’s protocols. Three
biological replicates were tested for each condition. Gene expression was
analyzed using GCRMA (http://www.bioconductor.org/packages/release/
bioc/html/gcrma.html). Differentially regulated genes were determined as
described (Kirienko and Fay, 2007) using a fold change R2 and a modified
Wilcoxon rank test with a minimal quotient of >1.45. Area-proportional Venn
diagrams were generated with BioInfoRx software (http://bioinforx.com/free/
bxarrays/overlap.php). We determined the number of genes expected by
chance as reported (Troemel et al., 2006).
Quantitative RT-PCR Analysis
RNA was collected as described above and reverse transcribed using random
decamers and the Retroscript kit (Ambion). Quantitative RT-PCR (qRT-PCR)
was performed with IQ SYBR green supermix (Bio-Rad) in a CFX96 system
(Bio-Rad). Primers were designed with IDT SciTools (IDT) and tested for effi-
ciency with a dilution series of template. At least three biological and two
technical replicates were measured for each gene and condition. All Ct values
were normalized against the snb-1 control gene. Fold changes were calculated
using the Pfaffl method and compared by using a two-tailed unpaired t test.
Primer sequences are available upon request.
Imaging
Animals were mounted onto agar pads and paralyzed with 20 mM levamisole
(Sigma). Images were acquired with a Zeiss AXIO Imager ZI microscope with
a Zeiss AxioCam HRm camera and Axiovision 4.6 (Zeiss) software.
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